UMN Pharma prolongs examination period for recombinant influenza vaccine

The multivalent vaccine ASP7374 which will be sold by Astellas is manufactured in insect cell lines.

UMN Pharma news release, Sept. 30, 2016

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny